Over the past years there has been increasing evidence that HSP90 interacts with a great number of molecules intracellularly, that are involved in the development and/or survival of cancer cells [9-11], allowing mutant proteins to retain or gain function, while permitting cancer cells to tolerate the imbalanced signaling that such oncoproteins create. This evidence concerns the gene HSP90AA1 and cancer.